crbp: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	2,851	0
Net increase in cash, cash equivalents, and restricted cash	9,785	2,846
Cash and cash equivalents at beginning of period	17,868	-
Cash and cash equivalents at end of period	27,653	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	2,851	0
Net increase in cash, cash equivalents, and restricted cash	9,785	2,846
Cash and cash equivalents at beginning of period	17,868	-
Cash and cash equivalents at end of period	27,653	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Corbus Pharmaceuticals Holdings, Inc. (CRBP)